1-6 of 6
Joel Fleury
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

Clinical Trials & Observations
Thierry Lamy, Gandhi Damaj, Pierre Soubeyran, Emmanuel Gyan, Guillaume Cartron, Krimo Bouabdallah, Rémy Gressin, Jérôme Cornillon, Anne Banos, Katell Le Du, Mohamed Benchalal, Marie-Pierre Moles, Steven Le Gouill, Joel Fleury, Pascal Godmer, Hervé Maisonneuve, Eric Deconinck, Roch Houot, Kamel Laribi, Jean Pierre Marolleau, Olivier Tournilhac, Bernard Branger, Anne Devillers, Jean Philippe Vuillez, Thierry Fest, Philippe Colombat, Valérie Costes, Vanessa Szablewski, Marie C. Béné, Vincent Delwail
Journal: Blood
Blood (2018) 131 (2): 174–181.
https://doi.org/10.1182/blood-2017-07-793984
Published: 2018
Includes: Supplemental data
Journal Articles

R-DHA-Oxaliplatin before Autologous Stem Cell Transplantation Prolongs PFS and OS As Compared to R-DHA-Carboplatin and R-DHA-Cisplatin in Patients with Mantle Cell Lymphoma, a Subgroup Analysis of the LyMa Trial

Steven Le Gouill, MD PhD, Catherine Thieblemont, MD PhD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, Gandhi Damaj, MD, Thomas Gastinne, MD, Vincent Ribrag, Carla Araujo, MD, Eric Deconinck, MD PhD, Joel Fleury, MD, Pierre Morel, MD, Emmanuelle Nicolas-Virelizier, MD, Reda Bouabdallah, MD, Jamilé Frayfer, MD, Eric Jourdan, MD, Richard Delarue, MD, Laurence Sahnes, Alain Delmer, Anne Moreau, MD, Marie C Bene, PharmD,DPhil, Gilles Andre Salles, MD PhD, Herve Tilly, Thierry Lamy, Pr, MD PhD, Remy Gressin, MD, Olivier Hermine, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1496.
https://doi.org/10.1182/blood.V130.Suppl_1.1496.1496
Published: 2017
Journal Articles

Efficacy of the Ribvd Regimen in High Risk Mantle Cell Lymphoma Patients As Defined By the Mipic Prognostic Score: Identification of KI67, LDH and Performance Status As Most Important Prognostic Factors (PF). a French Lysa Group Study

Remy Gressin, MD, Anne Moreau, MD, Nicolas Daguindau, MD, Adrien Tempescul, MD, Sylvain Carras, MD, Jean-Michel Pignon, MD, Guillaume Cartron, MD PhD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Anne Schmitt, MD, Krimo Bouabdallah, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Lionel Karlin, MD, Fabrice Jardin, MD PhD, Luc Mathieu Fornecker, MD PhD, Selim Corm, MD, Joel Fleury, MD, Barbara Burroni, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5302.
https://doi.org/10.1182/blood.V128.22.5302.5302
Published: 2016
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013
Journal Articles

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Clinical Trials & Observations
Didier Blaise, Jacques Olivier Bay, Catherine Faucher, Mauricette Michallet, Jean-Michel Boiron, Bachra Choufi, Jean-Yves Cahn, Nicole Gratecos, Jean-Jacques Sotto, Sylvie François, Joel Fleury, Mohamad Mohty, Christian Chabannon, Karin Bilger, Gwenaelle Gravis, Frédéric Viret, Anne Chantal Braud, Valérie Jeanne Bardou, Dominique Maraninchi, Patrice Viens
Journal: Blood
Blood (2004) 103 (2): 435–441.
https://doi.org/10.1182/blood-2003-07-2236
Published: 2004